Financhill
Back

Evoke Pharma Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
26

EVOK
Evoke Pharma

Last Price:
4.31
Seasonality Move:
12.83%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Evoke Pharma Price Quote

$4.31
-0.69 (-13.8%)
(Updated: November 13, 2024 at 5:55 PM ET)

Evoke Pharma Key Stats

Sell
26
Evoke Pharma (EVOK) is a Sell

Day range:
$4.90 - $5.50
52-week range:
$3.54 - $17.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.24
P/B ratio:
1.38%

Volume:
73K
Avg. volume:
780.8K
1-year change:
-66.67%
Market cap:
$3.7M
Revenue:
$5.2M
EPS:
$-26.4

How Much Does Evoke Pharma Make?

Is Evoke Pharma Growing As A Company?

  • What Is Evoke Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.26%
  • What Is Evoke Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Evoke Pharma Stock Price Performance

  • Did Evoke Pharma Stock Go Up Last Month?
    Evoke Pharma share price went down by -3.66% last month
  • Did EVOK's Share Price Rise Over The Last Year?
    EVOK share price fell by -66.67% over the past 1 year

What Is Evoke Pharma 52-Week High & Low?

Evoke Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evoke Pharma?

  • How Much Debt Does Evoke Pharma Have?
    Total long term debt quarterly is $5M
  • How Much Cash Does Evoke Pharma Have?
    Cash and short term investments quarterly total is $9.2M
  • What Is Evoke Pharma’s Book Value Per Share?
    Book value per share is 3.63

Is Evoke Pharma Cash Flow Positive?

  • What Is EVOK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.5M
  • What Is Evoke Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.7M
  • What Is Evoke Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Evoke Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    EVOK return on invested capital is -115.56%
  • What Is Evoke Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -67.32%
  • What Is EVOK Return On Equity?
    ROE is a measure of profitability and is -1005.23%

Evoke Pharma Earnings Date & Stock Price

  • What Is Evoke Pharma's Stock Price Today?
    A single share of EVOK can be purchased today for 5.00
  • What Is Evoke Pharma’s Stock Symbol?
    Evoke Pharma trades on the nasdaq under the ticker symbol: EVOK
  • When Is Evoke Pharma’s Next Earnings Date?
    The next quarterly earnings date for Evoke Pharma is scheduled on March 14, 2025
  • When Is EVOK's next ex-dividend date?
    Evoke Pharma's next ex-dividend date is November 14, 2024
  • How To Buy Evoke Pharma Stock?
    You can buy Evoke Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Evoke Pharma Competitors

  • Who Are Evoke Pharma's Competitors?
    Below is a list of companies who compete with Evoke Pharma or are related in some way:
    • Eli Lilly and Co (LLY)
    • MEI Pharma Inc (MEIP)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Repligen Corp (RGEN)
    • Revance Therapeutics Inc (RVNC)

Evoke Pharma Dividend Yield

Evoke Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -147.37%
Revenue: 125.51% -20.96%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.00
Upside from Last Price: 260%

Major Shareholders

  • How many EVOK shares are owned by institutional investors?
    1.7M EVOK shares are owned by institutional investors
  • How many EVOK shares are owned by insiders?
    698.9K EVOK shares are owned by insiders